Rezultati pretraživanja
  1. “Every day at , we work together in support of a shared vision to become the most forward thinking company in the development of .” Hear from our team & apply to our open positions today:

  2. prije 17 sati
  3. prije 18 sati

    Thinking 'Equity & Economy'? Must read this piece....

  4. 4. velj

    Yes, but … including the information of the full genetic background of a patient (whole genome) would be even better! Real-world patient data is revolutionizing clinical trials

  5. for : Big steps taken in in 2019. : “The idea of collaboration, on a scale like this, with the speed to which these projects got done is pretty remarkable."

    Prikaži ovu nit
  6. 4. velj

    What role can play in advancing the management of ? Join us at Real-World Evidence 2020: Rare Diseases and Innovative Therapies to find out! View the full agenda and register to attend now at

  7. 4. velj

    Hybrid CSS-MCR studies can be advantageous in generating to answer questions efficiently and effectively. Read more in our blog post

    ICON Blog Post January 2020
  8. 4. velj

    This , we have highlighted a selection of our top -related articles that we have brought to you on The Evidence Base®! Discover more now:

  9. In our new , David Thompson of provides his insights into the role of real-world evidence in regulatory decisions. Watch the full video in full at

  10. 3. velj

    ✨🔋NEW PARTNER! With Datametrix, we will power and bring insights on the realities of clinical practice. This is very timely as it follows the recent guidance calls for more use of !

  11. 2. velj

    Jeff Trotter has some predictions for in 2020. The first: novel applications for . Read more.

  12. Jeff Trotter has some predictions for 2020. But first, how does his 2019 list hold up?

  13. 30. sij

    In this first instalment of his regular column, Louis Gautier, Commissioning Editor of exclusively shares some of his top , and trial picks from the recent journal editions. Read now:

  14. 29. sij

    The use of is expanding to design, test and review treatments, but challenges persist as in the U.S. and Europe continue to express doubts. Our recent survey sheds light on the perception gap.

  15. 29. sij

    ., of , exclusively discusses the importance, benefits and challenges of achieving in . Read now:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.